Mass Spectrometric Characterization of Narcolepsy-Associated Pandemic 2009 Influenza Vaccines
Open Access
- 30 October 2020
- Vol. 8 (4), 630
- https://doi.org/10.3390/vaccines8040630
Abstract
The onset of narcolepsy, an irreversible sleep disorder, has been associated with 2009 influenza pandemic (pH1N1) infections in China, and with ASO3-adjuvanted pH1N1 vaccinations using Pandemrix in Europe. Intriguingly, however, the increased incidence was only observed following vaccination with Pandemrix but not Arepanrix in Canada. In this study, the mutational burden of actual vaccine lots of Pandemrix (n = 6) and Arepanrix (n = 5) sourced from Canada, and Northern Europe were characterized by mass spectrometry. The four most abundant influenza proteins across both vaccines were nucleoprotein NP, hemagglutinin HA, matrix protein M1, with the exception that Pandemrix harbored a significantly increased proportion of neuraminidase NA (7.5%) as compared to Arepanrix (2.6%). Most significantly, 17 motifs in HA, NP, and M1 harbored mutations, which significantly differed in Pandemrix versus Arepanrix. Among these, a 6-fold higher deamidation of HA146 (p.Asn146Asp) in Arepanrix was found relative to Pandemrix, while NP257 (p.Thr257Ala) and NP424 (p.Thr424Ile) were increased in Pandemrix. DQ0602 binding and tetramer analysis with mutated epitopes were conducted in Pandemrix-vaccinated cases versus controls but were unremarkable. Pandemrix harbored lower mutational burden than Arepanrix, indicating higher similarity to wild-type 2009 pH1N1, which could explain differences in narcolepsy susceptibility amongst the vaccines.This publication has 41 references indexed in Scilit:
- Genome Wide Analysis of Narcolepsy in China Implicates Novel Immune Loci and Reveals Changes in Association Prior to Versus After the 2009 H1N1 Influenza PandemicPLoS Genetics, 2013
- Incidence of narcolepsy in Norwegian children and adolescents after vaccination against H1N1 influenza ASleep Medicine, 2013
- Increased risk of narcolepsy in children and adults after pandemic H1N1 vaccination in FranceBrain, 2013
- ImmunoChip Study Implicates Antigen Presentation to T Cells in NarcolepsyPLoS Genetics, 2013
- Increased Incidence and Clinical Picture of Childhood Narcolepsy following the 2009 H1N1 Pandemic Vaccination Campaign in FinlandPLOS ONE, 2012
- AS03 Adjuvanted AH1N1 Vaccine Associated with an Abrupt Increase in the Incidence of Childhood Narcolepsy in FinlandPLOS ONE, 2012
- The development of vaccine viruses against pandemic A(H1N1) influenzaVaccine, 2011
- AS03A‐Adjuvanted Influenza A (H1N1) 2009 Vaccine for Adults up to 85 Years of AgeClinical Infectious Diseases, 2010
- Narcolepsy is strongly associated with the T-cell receptor alpha locusNature Genetics, 2009
- Prevalence of narcolepsy in King County, Washington, USASleep Medicine, 2009